|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar
|
|
2
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar
|
|
3
|
Setia N, Agoston AT, Han HS, Mullen JT,
Duda DG, Clark JW, Deshpande V, Mino-Kenudson M, Srivastava A,
Lennerz JK, et al: A protein and mRNA expression-based
classification of gastric cancer. Mod Pathol. 29:772–784. 2016.
View Article : Google Scholar
|
|
4
|
Mazzocco M, Maffei M, Egeo A, Vergano A,
Arrigo P, Di Lisi R, Ghiotto F and Scartezzini P: The
identification of a novel human homologue of the SH3 binding
glutamic acid-rich (SH3BGR) gene establishes a new family of highly
conserved small proteins related to thioredoxin superfamily. Gene.
291:233–239. 2002. View Article : Google Scholar
|
|
5
|
Berleth ES, Masso-Welch PA, Kazim LA, Ip
MM, Mihich E and Ehrke MJ: Expression, tissue distribution, and
cellular localization of the antiapoptotic TIP-B1 protein. J Leukoc
Biol. 69:995–1005. 2001. View Article : Google Scholar
|
|
6
|
Tong F, Zhang M, Guo X, Shi H, Li L, Guan
W, Wang H and Yang S: Expression patterns of SH3BGR family members
in zebrafish development. Dev Genes Evol. 226:287–295. 2016.
View Article : Google Scholar
|
|
7
|
Song J and Shen SH: Effects of SH3BGRL3
overexpression on the proliferation and differentiation of human
acute promyelocytic leukemia cells. J China Med Univ. 48:338–341.
2019.
|
|
8
|
Lee MJ, Kim J, Kim MY, Bae YS, Ryu SH, Lee
TG and Kim JH: Proteomic analysis of tumor necrosis
factor-alpha-induced secretome of human adipose tissue-derived
mesenchymal stem cells. J Proteome Res. 9:1754–1762. 2010.
View Article : Google Scholar
|
|
9
|
Jiang M, Lash GE, Zeng S, Liu F, Han M,
Long Y, Cai M, Hou H, Ning F, Hu Y and Yang H: Differential
expression of serum proteins before 20 weeks gestation in women
with hypertensive disorders of pregnancy: A potential role for
SH3BGRL3. Placenta. 104:20–30. 2021. View Article : Google Scholar
|
|
10
|
Chiang CY, Pan CC, Chang HY, Lai MD, Tzai
TS, Tsai YS, Ling P, Liu HS, Lee BF, Cheng HL, et al: SH3BGRL3
protein as a potential prognostic biomarker for urothelial
carcinoma: A novel binding partner of epidermal growth factor
receptor. Clin Cancer Res. 21:5601–5611. 2015. View Article : Google Scholar
|
|
11
|
Yin L, Gao S, Shi H, Wang K, Yang H and
Peng B: TIP-B1 promotes kidney clear cell carcinoma growth and
metastasis via EGFR/AKT signaling. Aging (Albany NY). 11:7914–7937.
2019. View Article : Google Scholar
|
|
12
|
Xiang Z, Huang X, Wang J, Zhang J, Ji J,
Yan R, Zhu Z, Cai W and Yu Y: Cross-database analysis reveals
sensitive biomarkers for combined therapy for ERBB2+ gastric
cancer. Front Pharmacol. 9:8612018. View Article : Google Scholar
|
|
13
|
Nie Z, Cheng D, Pan C, Wei Z and Wang C
and Wang C: SH3BGRL3, transcribed by STAT3, facilitates
glioblastoma tumorigenesis by activating STAT3 signaling. Biochem
Biophys Res Commun. 556:114–120. 2021. View Article : Google Scholar
|
|
14
|
Lega IC and Lipscombe LL: Review:
Diabetes, obesity, and cancer-pathophysiology and clinical
implications. Endocr Rev. 41:bnz0142020. View Article : Google Scholar
|
|
15
|
Shimoyama S: Diabetes mellitus carries a
risk of gastric cancer: A meta-analysis. World J Gastroenterol.
19:6902–6910. 2013. View Article : Google Scholar
|
|
16
|
Sheng L, Peng H, Pan Y, Wang C and Zhu Y:
Evaluating the effect of diabetes on the prognosis of gastric
cancer using a propensity score matching method. J Gastrointest
Oncol. 11:999–1008. 2020. View Article : Google Scholar
|
|
17
|
Miao ZF, Xu H, Xu YY, Wang ZN, Zhao TT,
Song YX and Xu HM: Diabetes mellitus and the risk of gastric
cancer: A meta-analysis of cohort studies. Oncotarget.
8:44881–44892. 2017. View Article : Google Scholar
|
|
18
|
Faubert B, Solmonson A and DeBerardinis
RJ: Metabolic reprogramming and cancer progression. Science.
368:eaaw54732020. View Article : Google Scholar
|
|
19
|
Zhao L, Liu Y, Zhang S, Wei L, Cheng H and
Wang J and Wang J: Impacts and mechanisms of metabolic
reprogramming of tumor microenvironment for immunotherapy in
gastric cancer. Cell Death Dis. 13:3782022. View Article : Google Scholar
|
|
20
|
WHO Classification of Tumours Editorial
Board, . Digestive system tumours: WHO classification of tumours.
5th edition. volume 1. Lyon: IARC; 2019
|
|
21
|
Lugli A, Kirsch R, Ajioka Y, Bosman F,
Cathomas G, Dawson H, El Zimaity H, Fléjou JF, Hansen TP, Hartmann
A, et al: Recommendations for reporting tumor budding in colorectal
cancer based on the international tumor budding consensus
conference (ITBCC) 2016. Mod Pathol. 30:1299–1311. 2017. View Article : Google Scholar
|
|
22
|
Package Insert and PATHWAY anti-HER-2/NEU
(4B5) rabbit monoclonal primary antibody. German Created.
17.03.2020. 01–12. 2021
|
|
23
|
Kim CH, Kim SH, Park SY, Yoo J, Kim SK and
Kim HK: Identification of EGFR mutations by immunohistochemistry
with EGFR mutation-specific antibodies in biopsy and resection
specimens from pulmonary adenocarcinoma. Cancer Res Treat.
47:653–660. 2015. View Article : Google Scholar
|
|
24
|
Wolff AC, Hammond MEH, Allison KH, Harvey
BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P,
Hanna W, et al: Human epidermal growth factor receptor 2 testing in
breast cancer: American society of clinical oncology/college of
American pathologists clinical practice guideline focused update. J
Clin Oncol. 36:2105–2122. 2018. View Article : Google Scholar
|
|
25
|
Wang HL, Kim CJ, Koo J, Zhou W, Choi EK,
Arcega R, Chen ZE, Wang H, Zhang L and Lin F: Practical
immunohistochemistry in neoplastic pathology of the
gastrointestinal tract, liver, biliary tract, and pancreas. Arch
Pathol Lab Med. 141:1155–1180. 2017. View Article : Google Scholar
|
|
26
|
Ikeda T, Gion Y, Sakamoto M, Tachibana T,
Nishikori A, Nishimura MF, Yoshino T and Sato Y:
Clinicopathological analysis of 34 Japanese patients with
EBV-positive mucocutaneous ulcer. Mod Pathol. 33:2437–2448. 2020.
View Article : Google Scholar
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
28
|
Kemi N, Eskuri M, Ikäläinen J, Karttunen
TJ and Kauppila JH: Tumor budding and prognosis in gastric
adenocarcinoma. Am J Surg Pathol. 43:229–234. 2019. View Article : Google Scholar
|
|
29
|
Ulase D, Heckl S, Behrens HM, Krüger S and
Röcken C: Prognostic significance of tumour budding assessed in
gastric carcinoma according to the criteria of the international
tumour budding consensus conference. Histopathology. 76:433–446.
2020. View Article : Google Scholar
|
|
30
|
Yang HJ, Kang D, Chang Y, Ahn J, Ryu S,
Cho J, Guallar E and Sohn CI: Diabetes mellitus is associated with
an increased risk of gastric cancer: A cohort study. Gastric
Cancer. 23:382–390. 2020. View Article : Google Scholar
|
|
31
|
Kim YM, Kim JH, Park JS, Baik SJ, Chun J,
Youn YH and Park H: Association between triglyceride-glucose index
and gastric carcinogenesis: A health checkup cohort study. Gastric
Cancer. 25:33–41. 2022. View Article : Google Scholar
|
|
32
|
Karlin NJ, Buras MR, Kosiorek HE, Verona
PM and Cook CB: Glycemic control and survival of patients with
coexisting diabetes mellitus and gastric or esophageal cancer.
Future Sci OA. 5:FSO3972019. View Article : Google Scholar
|
|
33
|
Yuan LW, Yamashita H and Seto Y: Glucose
metabolism in gastric cancer: The cutting-edge. World J
Gastroenterol. 22:2046–2059. 2016. View Article : Google Scholar
|
|
34
|
Hu Y, Xu W, Zeng H, He Z, Lu X, Zuo D, Qin
G and Chen W: OXPHOS-dependent metabolic reprogramming prompts
metastatic potential of breast cancer cells under osteogenic
differentiation. Br J Cancer. 123:1644–1655. 2020. View Article : Google Scholar
|
|
35
|
Thankamony AP, Saxena K, Murali R, Jolly
MK and Nair R: Cancer stem cell plasticity-a deadly deal. Front Mol
Biosci. 7:792020. View Article : Google Scholar
|
|
36
|
Kalyanaraman B, Cheng G and Hardy M:
Therapeutic targeting of tumor cells and tumor immune
microenvironment vulnerabilities. Front Oncol. 12:8165042022.
View Article : Google Scholar
|
|
37
|
Janku F, Beom SH, Moon YW, Kim TW, Shin
YG, Yim DS, Kim GM, Kim HS, Kim SY, Cheong JH, et al:
First-in-human study of IM156, a novel potent biguanide oxidative
phosphorylation (OXPHOS) inhibitor, in patients with advanced solid
tumors. Invest New Drugs. 40:1001–1010. 2022. View Article : Google Scholar
|
|
38
|
Ruffell B and Coussens LM: Macrophages and
therapeutic resistance in cancer. Cancer Cell. 27:462–472. 2015.
View Article : Google Scholar
|
|
39
|
Gambardella V, Castillo J, Tarazona N,
Gimeno-Valiente F, Martínez-Ciarpaglini C, Cabeza-Segura M, Roselló
S, Roda D, Huerta M, Cervantes A and Fleitas T: The role of
tumor-associated macrophages in gastric cancer development and
their potential as a therapeutic target. Cancer Treat Rev.
86:1020152020. View Article : Google Scholar
|
|
40
|
Wang XL, Jiang JT and Wu CP: Prognostic
significance of tumor-associated macrophage infiltration in gastric
cancer: A meta-analysis. Genet Mol Res. 15:gmr150490402016.
View Article : Google Scholar
|
|
41
|
Oya Y, Hayakawa Y and Koike K: Tumor
microenvironment in gastric cancers. Cancer Sci. 111:2696–2707.
2020. View Article : Google Scholar
|
|
42
|
Mylod E, Lysaght J and Conroy MJ: Natural
killer cell therapy: A new frontier for obesity-associated cancer.
Cancer Lett. 535:2156202022. View Article : Google Scholar
|
